Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

NCT00976820 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: GSK2340274A
BIOLOGICAL: GSK2340273A

Sponsor

GlaxoSmithKline